Article info
PDFRheumatoid arthritis
After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries
- Correspondence to Dr Manuel Pombo-Suarez, Rheumatology Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela 15706, Spain; mpombosuarez{at}gmail.com
Citation
After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries
Publication history
- First published September 13, 2022.
Online issue publication
January 23, 2023
Article Versions
- Previous version (13 September 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.